Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
Jeffrey Wong et al. | ASTRO 2024
Menu
Menu
Authors: A Ndlovu
Jeffrey Wong et al. | ASTRO 2024
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Your go-to source for staying informed about our advancements.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.
